Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026
Rhea-AI Summary
Bausch Health (NYSE: BHC) will release its fourth quarter and full year 2025 financial results after market close on Wednesday, February 18, 2026. The company will host a live conference call and webcast at 5:00 p.m. U.S. EST to discuss results and provide a business update. Presentation materials and a replay of the call will be made available on the company's Investor Relations website prior to and after the call.
Positive
- None.
Negative
- None.
News Market Reaction – BHC
On the day this news was published, BHC declined 2.06%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
BHC fell 2.72% while peers were mixed: some modestly higher (e.g., ALVO +2.06%, INDV +1.48%, AMRX +1.37%) and others slightly lower (HCM -1.01%). This points to stock-specific trading rather than a coordinated sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 05 | Conference participation | Neutral | +2.6% | Announcement of participation in J.P. Morgan Healthcare Conference. |
| Dec 23 | Debt exchange results | Neutral | -1.9% | Final results and expiration of senior secured notes exchange offers. |
| Dec 08 | Early exchange results | Neutral | -0.3% | Early tender results for senior secured notes exchange offers. |
| Dec 01 | Business acquisition | Neutral | +11.0% | Solta Medical acquisition of Shibo Group’s aesthetics distribution business. |
| Nov 24 | Debt exchange launch | Neutral | +1.3% | Launch of offers to exchange certain existing senior secured notes. |
Over the past few months, Bausch Health has focused on balance sheet actions and strategic positioning. It launched and completed exchanges of senior secured notes into new 10.00% notes due 2032, with related 8-K disclosures, and its Bausch + Lomb unit refinanced term loans maturing in 2028 and 2031. Strategically, Solta Medical acquired its long-time Chinese distribution partner on Dec 1, 2025. More recently, the company prepared for the J.P. Morgan conference and signaled 2025 guidance reaffirmation, setting the stage for the upcoming earnings release on Feb 18, 2026.
Market Pulse Summary
This announcement schedules Bausch Health’s fourth quarter and full year 2025 results for February 18, 2026, with a conference call at 5:00 p.m. U.S. EST. It follows a period of debt exchanges, refinancing at Bausch + Lomb, and a strategic acquisition in the aesthetics business, all disclosed via recent filings and press releases. Investors may focus on how the upcoming report and business update relate to previously reaffirmed 2025 guidance and recent balance sheet actions.
Key Terms
webcast technical
AI-generated analysis. Not financial advice.
LAVAL, QC, Jan. 21, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release fourth quarter and full year 2025 financial results after market close on Wednesday, February 18, 2026. Bausch Health will host a live conference call and webcast at 5:00 p.m.
Conference Call Details
Date: Wednesday, February 18, 2026
Time: 5:00 p.m.
Webcast: http://ir.bauschhealth.com/events-and-presentations
A replay of the conference call will be available on the investor relations website.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
BHC-FINANCIAL
Investor Contact:
Garen Sarafian
ir@bauschhealth.com
(877) 281-6642 (toll-free)
Media Contact:
Katie Savastano
corporate.communications@bauschhealth.com
(908) 541-3785
View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-to-announce-fourth-quarter-and-full-year-2025-results-on-february-18-2026-302665838.html
SOURCE Bausch Health Companies Inc.
